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Activated T Cell Death In Vivo Mediated
by Proapoptotic Bcl-2 Family Member Bim
al., 1995; Ju et al., 1995). Signaling through the Fas
receptor directly activates apoptosis through the re-
cruitment and activation of caspase enzymes (Cohen,
David A. Hildeman,1,7,8 Yanan Zhu,2
Thomas C. Mitchell,3 Philippe Bouillet,4
Andreas Strasser,4 John Kappler,1,2,5
1997). Active caspases lead to apoptosis by cleavageand Philippa Marrack1,2,5,6
of substrates normally involved in cell structure and1Howard Hughes Medical Institute and
integrity (Earnshaw et al., 1999).Department of Medicine
Two strains of mice having “natural” mutations in ei-National Jewish Medical and Research Center
ther Fas (lpr mice) or FasL (gld mice) exist and are defec-2 Department of Biochemistry
tive in expression of either Fas protein or functional FasLand Molecular Genetics
protein (Nagata and Suda, 1995). Both lpr and gld miceUniversity of Colorado Health Sciences Center
have accumulations of abnormal T cells (CD4CD8Denver, Colorado 80206
TCR) in the periphery beginning at about 8 weeks3 Institute for Cellular Therapeutics
of age (Laouar and Ezine, 1994). These mice were usedUniversity of Louisville School of Medicine
in a few studies to show that Fas or FasL is involved inLouisville, Kentucky 40202
T cell death in vivo (Gillette-Ferguson and Sidman, 1994;4 The Walter and Eliza Hall Institute
Mogil et al., 1995; Singer and Abbas, 1994; Van Parijsof Medical Research
et al., 1998a). However, several other reports using lprMelbourne, Victoria 3050
and gld mice clearly show that activated T cells can dieAustralia
in vivo in the absence of Fas or FasL (Desbarats et al.,5 Department of Integrated Immunology and
1998; Gonzalo et al., 1994; Lohman et al., 1996; Miethke6 Department of Pharmacology
et al., 1996; Scott et al., 1993; Van Parijs et al., 1998b).University of Colorado Health Sciences Center
In contrast to Fas-mediated apoptosis, Bcl-2 regu-Denver, Colorado 80206
lates a separate pathway to death in T cells (Strasser
et al., 1995). Bcl-2 is the prototype member of a large
family of related proteins having pro- or antiapoptoticSummary
function (Chao and Korsmeyer, 1998; Newton and Stras-
ser, 1998). The Bcl-2 related proteins have been dividedAt the end of the T cell response, the majority of the
into three groups: prosurvival Bcl-2-like proteins, whichactivated T cells die. We activated V8 T cells with
share four regions of homology, BH1-4 domains; BAX-staphylococcal enterotoxin B (SEB) in vivo and moni-
like proteins, which are proapoptotic and contain threetored the expansion and deletion of V8 T cells. We
of the characteristic BH domains, BH1-3; and a veryfound that, in response to SEB, activated T cells died
large group of BH3-only proteins, which are also proapo-in vivo in the absence of Fas or TNF-R signaling but
ptotic and which contain only one of the characteristic
not when they overexpressed human Bcl-2. We also
domains, BH3 (Chao and Korsmeyer, 1998; Newton and
found that V8 T cells from Bim-deficient mice are
Strasser, 1998). There may exist an interdependence
resistant to SEB-induced deletion. While Bim levels between proapoptotic Bcl-2 family members, with BH3-
did not change, endogenous Bcl-2 levels within V8 only proteins requiring Bax-like proteins to cause apo-
T cells decrease following SEB injection. Thus, the ptosis (Zong et al., 2001). Moreover, the Bax-like pro-
death of superantigen-stimulated T cells in vivo is me- teins have a more global tissue distribution, while the
diated by Bim and may be modulated by a decrease BH3-only proteins have a more tissue-specific distribu-
in Bcl-2. tion, suggesting that BH3-only proteins may be tissue
specific in their action (Hsu and Hsueh, 2000; Kiefer et
Introduction al., 1995; Kitada et al., 1998; O’Reilly et al., 2000; Penault-
Llorca et al., 1998). However, little has been done to
When T cells respond to an antigen in vivo, they become study the role played by Bcl-2 or Bcl-2-related proteins
activated and divide, and then most of them rapidly die. in the death of activated T cells in vivo.
The death of the responding T cells is important to T We became interested in a particular BH3-only Bcl-2
cell homeostasis and is also involved in peripheral T family member named Bim, which stands for Bcl-2 inter-
cell tolerance. Elucidation of the molecular mechanisms acting mediator of death (Hsu et al., 1998; O’Connor et
involved in this death is important to further our under- al., 1998). The reasons we chose to study Bim were
standing of how productive immune responses occur 4-fold. First, mice deficient in Bim developed autoimmu-
and how autoimmunity is prevented. The molecular nity, implying possible defects in T cell tolerance (Bouil-
let et al., 1999). Second, Bim-deficient mice had elevatedmechanism by which activated T cells die in vivo is
numbers of normal single positive T cells in the peripheryunder debate. Fas was identified as a death factor for
(Bouillet et al., 1999). Third, T cells from these miceT cells activated in vitro (Brunner et al., 1995; Dhein et
displayed increased survival in vitro, similar to hBcl-2
transgenic mice (Bouillet et al., 1999). Fourth, Bim-deficient7 Correspondence: david.hildeman@chmcc.org
T cells were completely susceptible to Fas-mediated apo-8 Present Address: NRB1563, Division of Immunobiology, Children’s
ptosis, indicating that Bim plays no role in Fas-mediatedHospital Medical Center, 3333 Burnet Avenue, Cincinnati, Ohio
45229. apoptosis (Bouillet et al., 1999). Given the opposing ef-
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Figure 1. Fas, TNFR-Independent, Bcl-2-
Dependent Activated T Cell Death In Vivo
Groups of triple mutant (lpr, TNFRI/,
TNFRII/; filled circles), gld (open circles),
BL/6 (open squares), or hBcl-2 Tg (filled
squares) mice were injected intravenously
(i.v.) with 150g SEB. Three mice/group were
left uninjected and analyzed at time zero. At
the indicated time points, three mice/group
were sacrificed, and their LN and spleen cells
were stained with antibodies against CD4,
CD8, V8, and V2 and analyzed by flow cy-
tometry. Results show the percentages of
CD4 or CD8 T cells expressing V8 SEM.
Percentages of nonactivated V2 T cells (X
symbols) from hBcl-2 Tg mice are indicated
by the dashed line. Significant differences be-
tween hBcl-2 Tg and all other groups of mice
were observed for days 7 and 10 after SEB
injection in both the LN and spleen (p  0.01
Mann-Whitney Test, Minitab for Windows).
Similar results were obtained in three inde-
pendent experiments.
fects of Bim and Bcl-2 on peripheral T cell survival, SEB reactive V8 T cells in the lymph node and spleen.
V8 T cells in either BL/6, triple mutant, or gld micewe studied the contributions of these molecules to the
death of T cells activated in the periphery. similarly expanded on day 2 and subsequently died to
a similar extent by day 10 (Figure 1). Similar results wereActivated T cells exhibit decreased levels of Bcl-2 at
the peak of the T cell response, just before they began obtained with 50 or 100 g SEB (data not shown). We
did observe a slight and reproducible effect of the ab-to die in vivo (Mitchell et al., 1999). We report that this
decrease in Bcl-2 contributed to their death, because sence of Fas and/or TNF on CD4V8 T cells on days
7 and 10 in the lymph node (Figure 1). Nonetheless,transgenic expression of Bcl-2 was sufficient to prevent
death. We also found that the majority of the activated the majority of the activated T cells died in vivo in the
absence of Fas or TNF signaling, similar to previouslyT cells died in vivo in the absence of Fas or TNF receptor.
Interestingly, we also found that Bim deficiency pre- published reports (Nguyen et al., 2000). In contrast,
transgenic expression of a human Bcl-2 gene withinvented the death of activated T cells in vitro and in vivo,
suggesting that the protective effects of Bcl-2 acted activated T cells afforded significant protection from
SEB-induced death in vivo (Figure 1). Thus, SEB-solely to neutralize Bim. Thus, our results demonstrate
molecular mechanisms involved in an “internal” death induced death of T cells in vivo occurs in the absence
of Fas and TNFR signaling but is preventable by Bcl-2pathway within activated T cells that involves the pro-
apoptotic Bcl-2 family member Bim and is accompanied overexpression.
by downregulation of the antiapoptotic molecule Bcl-2.
Endogenous Bcl-2 Levels Decrease at the Peak
of the T Cell ResponseResults
Because the human Bcl-2 transgene prevented T cell
death in vivo, we examined whether the levels of endog-Fas, TNFR-Independent, Bcl-2-Dependent Activated
T Cell Death In Vivo enous Bcl-2 changed upon T cell activation. Two days
after activation with SEB in vivo, mRNA levels for Bcl-2We previously observed that activated T cells could die
in vitro in the absence of Fas or TNFR signaling (Hilde- within activated T cells decreased approximately 7-fold
compared to resting T cells (Figure 2A). Interestingly,man et al., 1999). To find out whether this was also true
in vivo we injected groups of either triple mutant (lpr, mRNA levels for Bcl-xL were also decreased at the peak
of activation (Figure 2A). The decrease in Bcl-2 mRNATNFRI/, TNFRII/) mice, FasL mutant (gld) mice, hu-
man Bcl-2 transgenic mice, or C57BL/6 mice with staph- was mirrored by a similar reduction in Bcl-2 protein in
activated T cells (Figure 2B). This reduction has alsoylococcal enterotoxin B (SEB) and tracked the re-
sponding T cells over time. On days 2, 7, and 10 after been found in V3 T Cells from B10.BR mice given the
superantigen SEA and in LCMV-specific CD8 T cellsSEB injection (days 2, 6, and 12 for gld mice), we sacri-
ficed groups of mice and assessed the percentage of (Grayson et al., 2000; Mitchell et al., 1999). A significant
Bim/Bcl-2 Balance Controls Activated T Cell Death
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Figure 2. Downregulation of Bcl-2 and Bcl-
xL within Activated T Cells
(A) LN T cells from either uninjected (resting)
or SEB-injected (48 hr after 150 g i.v.) (acti-
vated) V8.2 TCR transgenic (VDO) mice
(Fenton et al., 1988) were sorted on a MoFlo
flow cytometer. Total RNA was isolated from
the two groups of T cells, and single-stranded
cDNA was synthesized by reverse transcrip-
tion. mRNA levels for -actin, Bcl-2, and Bcl-
xL were analyzed using an ABI 7700 Realtime
PCR machine (Applied Biosystems, Foster
City, CA) and primer/probe sets specific for
the indicated gene. Results show the signals
observed as a percentage of those obtained
for resting cells.
(B and C) Groups of C57BL/6 mice were either
injected i.v. with 150g SEB or left uninjected
(time 0) and were sacrificed at the indicated
time points (n  3/time point). LN cells were
removed and (B) were analyzed for Bcl-2 pro-
tein expression by intracellular immunofluo-
rescence staining and flow cytometric analy-
sis (Results show the mean fluorescence
intensity of anti-Bcl-2 staining in CD4V8
[open squares] or in CD8V8 [filled
squares] T cells  SEM.) or (C) were cultured
for 19 hr, then stained with antibodies against
V8 and either CD8 or CD4 and propidium
iodide (PI), and analyzed by flow cytometry.
Results show the percentage of either
CD4V8 (open squares) or CD8V8
(filled squares) T cells alive  SEM. Similar
results were obtained in three independent
experiments.
(D) VDO mice were injected i.v. with 150 g SEB and sacrificed 40 hr later. Their T cells were either mock infected or spin-fected with
retroviruses expressing Thy1.1 (MiT) or Bcl-2 and Thy1.1 (MiT-Bcl-2), as previously described (Mitchell et al., 2001). After 24 hr in culture,
cells were stained for CD4, CD8, V8, and Thy1.1 and analyzed for death using live/dead gating as previously described (Marrack et al., 1999;
Mitchell et al., 2001). Results show the percent of CD4Thy1.1 (open bars) or CD8 Thy1.1 (filled bars) cells alive  SD. Similar results were
obtained in three independent experiments.
decrease in Bcl-2 was not observed in nonactivated T after infection (Figures 3A and 3B). However, overex-
pression of the BH-3 only proteins, Bad, BimL, andcells from the same animals (Mitchell et al., 1999, and
data not shown). The decrease in Bcl-2 within activated BimEL, greatly accelerated the death of both CD4 and
CD8 T cells (Figures 3A and 3B). Thus, Bim and BadT cells was correlated with their decreased ability to
survive in culture (Figure 2C). Further, restoration of Bcl- are potent killers of activated T cells in vitro.
2 within activated T cells via retrovirus prevented their
death (Figure 2D). Therefore, just before activated T cells Bim Mediates Activated T Cell Death In Vitro
and In Vivobegin to die in vivo, the levels of Bcl-2 within these cells
decrease, and overexpression of Bcl-2 is sufficient to Because we observed that Bim accelerated the death
of activated T cells in culture, we evaluated whether theprevent their death.
absence of Bim could promote survival of these same
types of T cells. To do this, we injected Bim/ or Bim/Retroviral Overexpression of Bim Accelerates
Activated T Cell Death mice with SEB and, 48 hr later, sacrificed the mice,
cultured their T cells for various times, and assessedThe results with Bcl-2 suggested that a proapoptotic
Bcl-2 family member(s) might be involved in activated death. As expected, activated T cells from Bim/ mice
died rapidly in vitro, with only 42.9% of CD4V8 TT cell death. To screen for potential candidates, we
cloned cDNAs for Bax, Bad, BimEL, and BimL into the cells alive and only 23.6% of CD8V8 T cells alive
after 18 hr (Figure 4). In contrast, the death of Bim/-retroviral expression plasmid, MiT, in which expression
of Thy1.1 is used as a marker for infected cells (Mitchell activated T cells was significantly reduced, with 90.48%
of CD4V8 T cells alive and only 84.64% of CD8V8et al., 2001). We then activated T cells in vivo with SEB,
removed the T cells, infected them with various retrovi- T cells alive after 18 hr (Figure 4). After 90 hr in culture,
more than half of the activated Bim/ T cells were stillruses, and tested the ability of specific genes to acceler-
ate death by assessing the survival of Thy1.1 (retrovi- alive (CD4V8, 67% alive; CD8V8, 50.9% alive)
while almost all of the activated Bim/ T cells wererally infected) cells over time in culture. Compared to
vector alone, overexpression of Bax slightly increased dead (CD4V8, 6.5% alive; CD8V8, 1.6% alive).
Therefore, the absence of Bim greatly increased thethe death of CD4 T cells at both 18 and 24 hr after
infection and had no effect on CD8 T cells until 40 hr survival of activated T cells in culture.
Immunity
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Figure 4. Absence of Bim Promotes Survival of Activated T Cells In
Vitro
Bim/ and Bim/ mice were injected i.v. with 150 g SEB. Forty-
eight hours later, mice were sacrificed, and their LN T cells were
cultured for the indicated time points. Cells from either Bim/ (open
squares) or Bim/ (filled squares) mice were then stained with anti-
bodies against V8 and either CD8 or CD4 and propidium iodide
and analyzed by flow cytometry. Results show (A) the percent ofFigure 3. BimEL, BimL, and Bad Accelerate the Death of Activated T
CD4 V8 cells alive  SD or (B) the percent of CD8 V8 cellsCells
aliveSD. Similar results were obtained in three independent exper-VDO mice were injected i.v. with 150 g SEB and sacrificed 24 hr
iments.later. LN T cells were either mock infected (open diamonds) or spin-
fected with retroviruses expressing either Thy1.1 alone (MiT, open
triangles) or Thy1.1 and the indicated genes (MiT-Bax [open circles], To determine if Bim is also required for the death ofMiT-Bad [X symbols], MiT-BimL [open squares], MiT-BimEL [filled
activated T cells in vivo, groups of Bim/, Bim/, orsquares]) and cultured at 37	C. At indicated time points, cells were
Bim/ mice were injected with SEB and sacrificed onstained for CD4, CD8, V8, and Thy1.1 and analyzed for death using
live/dead gating (Marrack et al., 1999; Mitchell et al., 2001). Results various days thereafter. SEB caused an increase in both
show the percent of CD4Thy1.1 (A) or CD8Thy1.1 (B) cells the percentage and the total numbers of V8 T cells
aliveSD. Similar results were obtained in three independent exper- in all types of mice 2 days after SEB injection (Figure
iments. (C) Either C57BL/6 (open bars) or Bim/ (closed bars) mice 5). We observed a subsequent large decrease in bothwere injected i.v. with 150 g SEB and sacrificed 24 hr later. LN T
the percentage and the absolute number of V8 T cellscells were either mock infected or spin-fected with retroviruses
in Bim/ mice (Figure 5). In Bim/ mice, the decreaseexpressing either Thy1.1 alone (MiT), MiT-BimL, or MiT-BimEL and
cultured at 37	C. Results show the percent of CD4Thy1.1 cells in the percentage of V8 T cells was slightly delayed
alive after 24 hr in culture  SD. compared to that in Bim/ mice (Figure 5). By contrast,
in Bim/ mice, there was only a small decrease in the
percentage of either CD4V8 or CD8V8 T cells
(Figure 5). Further, while there was a partial decreaseTo address the possibility that Bim deficiency ren-
dered T cells “apoptosis-resistant” because of altered in the absolute numbers of either CD4V8 or
CD8V8 T cells in the lymph node, there was virtuallydevelopment, we retrovirally transduced T cells from
Bim/ or Bim/ mice with BimEL and BimL. Retroviral no loss of either CD4V8 or CD8V8 T cells in the
spleen. Therefore, roughly 80% of the SEB reactive V8overexpression of either BimEL or BimL killed Bim/ and
Bim/ T cells equally (Figure 3C). T cells in vivo were prevented from death by Bim defi-
Bim/Bcl-2 Balance Controls Activated T Cell Death
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Figure 5. Bim Is Required for the Superantigen-Induced Death of Activated T Cells In Vivo
(A) Bim/ (open squares), Bim/ (open circles), or Bim/ (filled squares) littermates were either left untreated (day 0, n  3/group) or were
injected i.v. with 150 g SEB and sacrificed on day 2 (n  4/group), day 7 (n  4/group), day 10 (n  3/group), or day 20 (n  3/group). Cells
from LNs or spleen were stained with antibodies against CD4, CD8, V8, and V2. Results show the percentages of CD4 or CD8 T cells
expressing V8  SEM (upper row) and the total numbers of CD4 or CD8V8 cells/mouse  SEM (lower row). Significant differences
between Bim/ or Bim/ and Bim/ mice were observed for days 7, 10, and 20 post-SEB injection for all graphs (p  0.01 Mann-Whitney
Test). Data were pooled from three independent experiments.
ciency. Numbers of nonresponding CD4 or CD8V2 (VDO) mice either left uninjected (resting) or 48 hr after
superantigen injection and subjected their whole-cellT cells did not change significantly over the 20 day
period analyzed in any of the mice. Preliminary experi- lysates to SDS-PAGE and Western blotting for all three
Bim isoforms. Although alternative splicing can give risements have shown that, 10 days after SEB treatment
in vivo, the remaining V8 Bim/ cells responded to to three different Bim proteins, T cells express predomi-
nantly BimEL and a small amount of BimL (Figure 6). Theantigen in vitro better than V8 cells Bim/ (data not
shown). Thus, Bim is required for SEB-induced activated protein bands corresponding to BimEL and BimL were
not observed in Western blots of cells from Bim-defi-T cell death in vivo.
Two recent reports have shown that memory T cells cient mice (data not shown). We were unable to detect
any BimS protein in any samples (data not shown). Fur-can persist in the nonlymphoid tissues of mice (Rein-
hardt et al., 2001; Masopust et al., 2001). To address ther, activation did not change the levels of BimEL or
BimL within T cells relative to the control housekeepingthe possibility that Bim deficiency has affected the traf-
ficking of cells to these tissues, we measured the num- protein -actin (Figure 6). Thus, the BimEL isoform is the
predominant isoform expressed in T cells and increasedbers of SEB reactive T cells in the liver and lung of
Bim/, Bim/, or Bim/ mice. On day 10 after SEB expression of the protein cannot be the mechanism by
which it unleashes its proapoptotic activity.injection, both the livers and lungs of Bim/ mice con-
tained roughly three to four times the number of V8
T cells compared to either Bim/ or Bim/ controls Bcl-2 Downregulation in Activated T Cells
Is Not Caused by Bim(data not shown). Therefore, our results are not ex-
plained by altered trafficking of activated T cells in To determine whether the decrease in Bcl-2 we ob-
served was dependent upon Bim, we compared Bcl-2Bim/ mice.
levels in resting and activated T cells from either Bim/
or Bim/ mice. Interestingly, nonactivated T cells fromT Cells Predominantly Express BimEL
Because both BimEL and BimL were able to accelerate Bim/ mice expressed about half the level of Bcl-2 that
was expressed by the same cells from Bim/ micethe death of activated T cells and the absence of Bim
conferred resistence to death in vivo, we determined (Figure 7). Following activation, Bcl-2 levels decreased
in cells from either Bim/ or Bim/ mice (Figure 7).which isoform(s) of Bim is expressed by T cells and
whether or not Bim levels are changed with T cell activa- Thus, while Bcl-2 levels were lower in Bim/ resting T
cells, they still decreased following activation, indicatingtion. To do this, we purified T cells from TCR chain
Immunity
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1996; Scott et al., 1993). The reason for this difference
in results probably lies in the experimental design. In
cases in which animals are repeatedly injected with su-
perantigens, roles for Fas have been observed. In exper-
iments such as those described here, in which animals
are exposed to a single dose of superantigen, death of
the activated T cells is more often found to be Fas
independent.
In other studies, investigators have suggested that
antigen and/or cytokine withdrawal leads to the death
of T cells activated in response to foreign antigens (Kur-
oda et al., 1996; Van Parijs et al., 1998b). Four observa-
tions support this notion. First, the majority of superanti-
gen is excreted within 24 hr of injection into mice and
therefore superantigen levels in animals are dropping
before the activated T cells start to die (Vabulas et al.,
1996). Second, the cytokine response to antigen peaksFigure 6. Expression of BimEL and BimL in Resting versus SEB Acti-
vated T Cells and then starts to drop before the T cells start to die
(Blank et al., 1997). Third, the death of activated T cellsSome of the negatively sorted T cells from the VDO mice used in
Figure 2A were lysed in lysis buffer. Equivalent numbers of resting following superantigen injection is prevented by admin-
(lane 1) or activated cells (lane 2) were loaded onto 12.5% SDS- istration of cytokines (Kuroda et al., 1996; Vella et al.,
PAGE gels, and the separated proteins were transferred to nitrocel- 1998). Finally, the death in vitro of T cells which have
lulose. Proteins were visualized by staining blots with antibodies to
been activated in vivo is prevented by culture with mem-Bim or -actin, followed by staining with anti-rabbit Ig-HRP antibod-
bers of the IL-2 family of cytokines (Mitchell et al., 1999;ies, and developed with enhanced chemiluminescence substrate.
Vella et al., 1997, 1998). Thus, one factor which contrib-Similar results were obtained in two independent experiments.
utes to the death of activated T cells in animals is proba-
bly the fact that cytokines, particularly members of the
IL-2 family, become limiting in the animal. This idea doesthat the activation-induced decrease in Bcl-2 is not
not, however, explain why cytokine withdrawal causescaused by Bim.
activated T cells to die, nor does it explain how adjuvants
prevent the death of these cells.Discussion
Here we suggest a mechanism that accounts for the
Fas-independent death of activated T cells. At the timeSeveral reports have suggested that Fas governs acti-
they begin to die, activated T cells contain lower levelsvated T cell death that occurs following superantigen
of the antiapoptotic protein Bcl-2 (Figure 2, Grayson etadministration (Mogil et al., 1995; Strasser et al., 1995;
al., 2000). The lower levels of Bcl-2 within activated TVan Parijs et al., 1996), while several other reports, in
cells could be partially due to limiting amounts of cyto-addition to the data shown here, have shown that super-
kines (Mitchell et al., 1999) which are known to increaseantigen-activated T cells die in the absence of Fas (Des-
Bcl-2 levels (Akbar et al., 1996; Vella et al., 1998). Low-barats et al., 1998; Gonzalo et al., 1994; Miethke et al.,
ered Bcl-2 levels likely contribute to activated T cell
death because restoring Bcl-2 levels within activated
T cells via transgene or retrovirus inhibits their death.
However, decreased expression of Bcl-2 is not sufficient
to drive the activated T cells to death. The proapoptotic
protein, Bim, must also be involved since superantigen-
activated T cells lacking Bim die much less readily, both
in vivo and in vitro. Hence, the balance between the
activity of Bcl-2 and Bim in activated T cells appears to
control their fate.
Apart from the loss of cytokines known to induce
it, we do not know the mechanism by which Bcl-2 is
downregulated in T cells following activation in vivo.
However, preliminary experiments indicate that the de-
crease in Bcl-2 may be partially due to reactive oxygen
species (ROS) which we have previously shown to be
involved in activated T cell death (Hildeman et al., 1999).
Figure 7. Bcl-2 Downregulation Occurs in Bim-Deficient Activated We have recently observed that a synthetic, catalytic
T Cells antioxidant, MnTBAP, significantly increased the levels
Bim/or Bim/ mice were either left uninjected or were injected of Bcl-2 but did not affect the expression of Bim in
with 150 g SEB and sacrificed 48 hr later. Lymph node cells from activated T cells (data not shown). Similarly, we have
either group of mice were stained for intracellular Bcl-2 levels. Re-
observed that culture of T cells under anaerobic condi-sults show the mean fluorescence intensity of anti-Bcl-2 staining in
tions, which decrease availability of oxygen for ROSCD4V8 (circles) or CD8V8 (squares) T cells from either Bim/
production, also increased Bcl-2 levels (data not shown).(filled symbols) or Bim/ (open symbols) mice  SD. Similar results
were obtained in three independent experiments. Therefore, it is possible that ROS, generated during the
Bim/Bcl-2 Balance Controls Activated T Cell Death
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(Becton Dickinson). APC FITC cells were considered dead if theyprocess of activation, decrease Bcl-2 levels, thereby
were also PI.increasing the Bim/Bcl-2 ratio within the cell.
To measure Bcl-2 levels, LN cells were first surface stained withWhile we demonstrate a requirement for Bim in medi-
anti-V8-FITC, anti-CD8Cyc, and anti-CD4APC for 1 hr at 4	C.
ating T cell death in vivo, we are still unclear as to the Cells were washed once with BSS wash buffer, followed by a wash
signals that control the function of Bim. One previous with BSS wash buffer containing 0.03% saponin (0.03% sap-BSS,
Sigma). Cells were then incubated with anti-Bcl-2-PE (clone 3F11)study demonstrated that Bim protein is induced upon
in 0.03% sap-BSS for 1 hr at 4	C. Cells were washed twice withgrowth factor withdrawal in a hematopoietic cell line
0.03% sap-BSS and resuspended in BSS wash buffer, and data on(Shinjyo et al., 2001), and neurons appear to increase
the stained cells were acquired on a FACSCalibur flow cytometer.Bim in response to NGF withdrawal (Putcha et al., 2001;
Data for at least 104 cells were analyzed using CellQuest software
Whitfield et al., 2001). However, we failed to observe (Becton Dickinson).
any changes in the level of Bim protein between resting For cell sorting, nylon wool enriched LN T cells from either unin-
jected or SEB-injected VDO mice were stained with anti-B220-and activated T cells (Figure 4A). Thus, while upregula-
Cyc and anti-MHC class II-FITC (clone Y3P), washed twice, andtion of Bim may be involved in the death of neurons or
negatively sorted for Cyc- and FITC-cells on a MoFlo flow cytometerBAF-3 cells, it is unlikely to be the mechanism by which
(CytoMation, Fort Collins, CO). Twenty million resting or activatedBim kills T cells in vivo. Another previous study showed
T cells were sorted. After sorting, a sample of the cells was stained
that BimEL and BimL are sequestered to the dynein motor with anti-CD3-PE, and cell purity was analyzed on a FACSCalibur
complex via binding to DLC1/LC8 (Puthalakath et al., flow cytometer. After sorting, resting cells were 91% CD3, and
SEB-activated cells were 98% CD3. Ten million cells were used for1999). Bim and LC8 are released from the dynein motor
RNA isolation, and ten million cells were lysed for Western blotting.complex following certain apoptotic stimuli, allowing
them to interact with antiapoptotic Bcl-2 molecules (Pu-
Quantitation of Bcl-2 mRNA Levelsthalakath et al., 1999). Even in cells that do not express
Ten million negatively sorted T cells from either resting or SEB-Bim, LC8 was still released from dynein following apo-
activated VDO mice were resuspended in 1 ml Triazol reagentptotic stimuli (Puthalakath et al., 1999). Thus, perhaps
(Gibco BRL, Gaithersberg, MD). Total RNA was extracted from the
the apoptotic signal does not act directly on the Bim T cells using the Triazol Kit (Gibco BRL) according to the manufactur-
protein but instead acts on either LC8 or on another er’s instructions. cDNA was synthesized from the RNA by reverse
transcription using SuperScript Choice. RNA quantitation for spe-component of the dynein motor complex.
cific genes was performed by real-time PCR using an ABI Prism
7700 Sequence detection system (Applied Biosystems, Norwalk,
Experimental Procedures CT). Real-time PCR primers used for Bcl-2: forward 5
-TGGGATGCC
TTTGTGGAACTAT-3
, reverse 5
-AGAGACAGCCAGGAGAAATCA
Mice and Injections AAC-3, probe 5
-FAM-TGGCCCCAGCATGCGACCTC-TAMRA-3
.
Female C57BL/6 (H-2b) and B6Smn.C3H-Tnfsf6gld (gld) mice were Real-time PCR primers used for Bcl-xL: forward 5
-CTGGGACACTT
purchased from the Jackson Laboratory (Bar Harbor, ME) and were TTGTGGATCTCT-3
, reverse 5
-GAAGCGCTCCTGGCCTTT-3
, probe
used between 6 and 8 weeks of age. Heterozygous breeding pairs 5
-FAM-CAATGCAGCAGCCGAGAGCCG-TAMRA-3
. Real-time PCR
of lpr/, p55/, p75/ mutant mice, a generous gift from Dr. David primers used for -actin: forward 5
-GACGGCCAAGTCATCACTA
Lynch (Immunex Corporation, Seattle, WA), were used to produce TTG-3
, reverse 5
-GAAGGAAGGCTGGAAAAGAGC-3
, probe 5
-
lpr/, p55/, p75/ mice. Such animals were used between 5 and FAM-CAACGAGCGGTTCCGATGCCC-TAMRA-3
. The difference in
7 weeks of age since the homozygous deficient animals begin to Bcl-2 mRNA level was calculated as follows: fold change  2x, x 
accumulate CD4, CD8, B220 T cells after 8 weeks of age (Laouar the difference in cycle count between resting and activated T cells
and Ezine, 1994). Mutant genotypes of lpr/, p55/, p75/ mice after normalization to -actin.
were confirmed by PCR on genomic DNA from ear clips and by
flow cytometry. V8.2 TCR transgenic mice (VDO) and hBcl-2
Retroviral Transduction of T Cellstransgenic mice were described previously (Fenton et al., 1988;
The MSCV retroviral delivery system into which we exchanged GFPStrasser et al., 1991). Bim-deficient mice were also described pre-
for Thy1.1 to mark infected cells was used to infect T cells and isviously and were backcrossed 12 times to C57BL/6 (Bouillet et al.,
referred to as MiT for MSCV-IRES-Thy1.1 (Mitchell et al., 2001). Bad,1999). All animals were kept under specific pathogen-free conditions
Bax, BimEL, and BimL cDNAs were amplified by polymerase chainin the Biological Resource Center at National Jewish Medical and
reaction from cDNA of resting or SEB-activated T cells isolated fromResearch Center. Mice were injected via the tail vein (i.v.) with 150
C57BL/10 mice using the following primers: Bad, forward, 5
-CTAGCg SEB (Sigma, St. Louis, MO) in a volume of 0.25 mls balanced
GGCCGCATGGGAACCCCAAAGCAGC-3
, reverse, 5
-GCCTTAATTsalt solution (BSS).
AATCACTGGGAGGGGGTGGAG-3
; Bax, forward, 5
-TCGTAGATCT
ATGGACGGGTCCGGGGAGCAGCT-3
, reverse, 5
-ATTAGCGGCC
GCTCAGCCCATCTTCTTCCAGAT-3
; BimEL and BimL, forward,Flow Cytometry and Cell Sorting
For assessment of V8 or V2 T cells following SEB injection, we 5
-TAACGGATCCATGGCCAAGCAACCTTCTGA-3
, reverse, 5
-ATA
GCGGCCGCTCAATGCCTTCTCCATACCAG-3
. The PCR productsperformed four-color flow cytometric staining on lymph node (LN) or
spleen cells. Cells were incubated with anti-V8-FITC (clone F23.1), were cloned into MiT, and their correct sequences were verified by
DNA sequencing. MiT-Bcl-2 was previously described (Mitchell etanti-CD8Cyc, anti-CD4APC, and anti-V2-PE in the presence of
blocking solution (anti-Fc receptor, 2.4G2 supernatant containing al., 2001). Retroviruses used for infecting T cells were produced by
cotransfecting 293 cells with individual MiT vectors and pCLeco (a10 g/ml human  globulin, and 5% normal mouse serum) for 1 hr at
4	C. Cells were then washed twice with BSS wash buffer (BSS con- helper plasmid expressing the structural proteins of Maloney murine
leukemia virus, a generous gift of Dr. Inder Verma) (Naviaux et al.,taining and 2% FBS). Data on at least 104 cells were acquired on
a FACSCalibur flow cytometer and analyzed using CellQuest soft- 1996).
In brief, individual MiT vectors and pCLeco or pCLeco aloneware (Becton Dickinson Immunocytometry Systems, San Jose, CA).
To assess cell viability, LN cells were cultured at 37	C for the (mock) were mixed at a ratio of 5:1 and 250 mM CaCl2, and the DNA
precipitate was added to 293 cells and incubated overnight at 37	C.indicated times and then stained with anti-V8-FITC and either anti-
CD4APC or anti-CD8APC in the presence of blocking solution for After overnight culture, supernatants from 293 cells were aspirated
and replaced with fresh media (D-MEM with 10% FBS) and incu-1 hr at 4	C. Stained cells were washed twice and resuspended in
BSS wash buffer containing 0.5 g/ml propidium iodide, and data bated at 37	C. Retroviral-containing supernatants were harvested
15–18 hr later, mixed with nylon wool enriched T cells from SEB-on the stained cells were acquired on a FACSCalibur flow cytometer.
Data for at least 104 cells were analyzed using CellQuest software injected VDO mice and 8g/ml polybrene (Sigma), and centrifuged
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